Brief: Kezar Life Sciences Reports First Quarter 2023 Financial Results
May 11 (Reuters) - Kezar Life Sciences Inc KZR.O :
* KEZAR LIFE SCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q1 LOSS PER SHARE $0.31
* Q1 EARNINGS PER SHARE VIEW $-0.29 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw7Scs00a
Further company coverage: KZR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kezar Life Sciences
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM